Men taking valproate advised by MHRA to use effective contraception The regulator advises that males and their partners should use effective contraception during, and for at least three months after, valproate treatment.…
Prescribing dilemma: balancing risk and benefit when treating sertraline sexual dysfunction The first of a new series of articles exploring real-world dilemmas that pharmacist prescribers encounter in clinical practice.…
One-third of adult social care providers say medicines support from community pharmacy has improved over past year Respondents to the Care Quality Commission survey said they typically received advice from community pharmacy on medicines side effects, over-the-counter medicine and safe medicines administration.…
Suicidal ideation more commonly reported as reaction to semaglutide than for all other drugs, study finds Researchers report that, for people taking antidepressants, suicidal ideation was reported 4.45 times as likely for semaglutide compared with adverse drug reactions from all other drugs.…
Deaths related to drug misuse in Scotland rose by almost 12% in 2023 The National Records of Scotland data show that opioids were implicated in 80% of the misuse-related deaths in 2023.…
Pharmacy initiative results in 300% increase in inhalers being returned for sustainable disposal Five pharmacies in and around Edinburgh spent ten weeks adding stickers to dispensing bags to encourage patients to return inhalers to the pharmacy.…
More than 20,000 inhalers returned since November 2023 through recycling pilot Exclusive: Since its launch in November 2023, 20,400 inhalers have been returned through the ‘Re-Hale’ scheme, which operates across 78 locations in East Kent.…
Sepsis: diagnosis and management How to manage suspected sepsis to minimise risk to patients while supporting efforts to improve antimicrobial stewardship.…
NHS rolls out new multiple sclerosis injection that cuts treatment time by 90% The NHS will be one of the first healthcare systems in the world to offer the new injection in the “coming weeks”.…
Joint guidance for asthma recommends replacing SABA with corticosteroid inhalers The draft guidance proposes the use of combined inhaled corticosteroid/formoterol inhalers over previously preferred short-acting beta agonists.…
